MMC
67
2
KHC
20
2
UA
57
-8
HCA
48
2
V
72
-4
NKE
39
-3
TAP
63
2
STZ
52
-5
SJM
45
9
LLY
53
6
RF
67
-2
NEE
59
5
DLTR
40
-2
AMT
45
2
OI
38
-5
FFIV
69
2
VNO
68
3
ABBV
50
8
VRTX
55
2
TEL
66
-3
MMC
67
2
KHC
20
2
UA
57
-8
HCA
48
2
V
72
-4
NKE
39
-3
TAP
63
2
STZ
52
-5
SJM
45
9
LLY
53
6
RF
67
-2
NEE
59
5
DLTR
40
-2
AMT
45
2
OI
38
-5
FFIV
69
2
VNO
68
3
ABBV
50
8
VRTX
55
2
TEL
66
-3
Financhill
Back

Lexicon Pharmaceuticals Vs. Halozyme Therapeutics Industry Stock Comparison

Sell
26

LXRX
Lexicon Pharmaceuticals

Last Price:
0.84
Seasonality Move:
18.61%
Buy
53

HALO
Halozyme Therapeutics

Last Price:
47.56
Seasonality Move:
15.77%
Sell
26
Lexicon Pharmaceuticals (LXRX) is a Sell

Is Lexicon Pharmaceuticals a Buy, Sell or Hold?

  • The current Lexicon Pharmaceuticals [LXRX] share price is $0.82. The Score for LXRX is 26, which is 48% below its historic median score of 50, and infers higher risk than normal.
  • LXRX is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
53
Halozyme Therapeutics (HALO) is a Buy

Is Halozyme Therapeutics a Buy, Sell or Hold?

  • The current Halozyme Therapeutics [HALO] share price is $47.79. The Score for HALO is 53, which is 6% above its historic median score of 50, and infers lower risk than normal.
  • HALO is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

LXRX Stock Price Chart

What is Lexicon Pharmaceuticals's stock price today?

  • The Lexicon Pharmaceuticals share price today is $0.82
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and LXRX is experiencing slight selling pressure.

HALO Stock Price Chart

What is Halozyme Therapeutics's stock price today?

  • The Halozyme Therapeutics share price today is $47.79
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and HALO is experiencing buying pressure, which is a positive indicator for future bullish movement.

LXRX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.23 Sell
Relative Strength Index (14 RSI): 27.37 Sell
Chaikin Money Flow: 29373 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (0.87 - 1.71) Sell
Bollinger Bands (100): (1.3 - 2.02) Sell

HALO Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -2.26 Sell
Relative Strength Index (14 RSI): 41.07 Sell
Chaikin Money Flow: 837944 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (46.59 - 58.19) Sell
Bollinger Bands (100): (51.1 - 60.64) Sell

LXRX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 0.85 Sell
20-day SMA: 1.14 Sell
50-day SMA: 1.49 Sell
200-day SMA: 1.84 Sell
8-day EMA: 0.89 Sell
20-day EMA: 1.11 Sell
50-day EMA: 1.39 Sell
200-day EMA: 1.69 Sell

HALO Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 46.13 Buy
20-day SMA: 52.96 Sell
50-day SMA: 54.19 Sell
200-day SMA: 49.33 Sell
8-day EMA: 48.36 Sell
20-day EMA: 50.94 Sell
50-day EMA: 53.37 Sell
200-day EMA: 50.43 Sell

Lexicon Pharmaceuticals Earnings Growth & LXRX Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.04 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.12 per share, and an increase next year of $0.22 per share.

Halozyme Therapeutics Earnings Growth & HALO Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.21 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.35 per share, and an increase next year of $0.56 per share.

Lexicon Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Halozyme Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):